Maltese

2023 - 3 - 8

Post cover
Image courtesy of "PRNewswire"

Maltese Patient Received World's First ND1-LHON Gene Therapy ... (PRNewswire)

PRNewswire/ -- Matthias Szabo Zarb, a Maltese college student, was diagnosed with Leber hereditary optic neuropathy caused by ND1 mutation (ND1-LHON) two...

NFS-02 has been used to treat multiple patients in the investigator-initiated clinical trial (IIT) in China and received orphan drug designation and IND approval from the U.S. The National Alliance for Rare Diseases Support organized a press conference where the Speaker of the Maltese Parliament delivered a speech. The study included 149 patients from China and 10 patients from Argentina. In 2017, Professor Li Bin, the former director of the Ophthalmology Department of Tongji Hospital of Huazhong University of Science and Technology, launched the world's largest sample size clinical trial for gene therapy for ND4-LHON. Michelle Muscat, the chairman of the Malta National Alliance for Rare Diseases Support, contacted Neurophth. The Embassy of China in Malta expressed their gratitude to Neurophth for their support in treating international patients.

Post cover
Image courtesy of "MaltaToday"

Maltese say country 'less fair' than in 2017 (MaltaToday)

Eurobarometer survey finds only 53% think in Malta everyone has an equal opportunity to get ahead in life – five years earlier it was 73%

In fact, in the EU as a whole 47% believe they enjoy equal opportunities like everyone else to move ahead in life, in Malta 53% believe so. And while in the EU as a whole 37% believe that people generally do not get what they deserve, 35% of Maltese think the same. And while the percentage of those who believe that in Malta people get what they deserve, the percentage of those who disagree has increased by 9 points.

Explore the last week